Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ObsEva SA (OBSV)

2.98   0.08 (2.76%) 09-20 01:14
Open: 2.9 Pre. Close: 2.9
High: 3 Low: 2.88
Volume: 362,168 Market Cap: 143M
ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. The company is headquartered in Plan-Les-Ouates, Geneve and currently employs 45 full-time employees. The firm develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban (OBE001), an oral oxytocin receptor antagonist undergoing phase 3 of clinical trials, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor (phase 2a of clinical trials).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.003 - 3.017 3.017 - 3.03
Low: 2.846 - 2.862 2.862 - 2.877
Close: 2.955 - 2.981 2.981 - 3.003

Technical analysis

as of: 2020-09-18 4:34:03 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.67     One year: 4.28
Support: Support1: 2.78    Support2: 2.56
Resistance: Resistance1: 3.14    Resistance2: 3.67
Pivot: 2.80
Moving Average: MA(5): 2.87     MA(20): 2.77
MA(100): 3.58     MA(250): 3.90
MACD: MACD(12,26):     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 73.23     %D(3): 61.91
RSI: RSI(14): 56.43
52-week: High: 9.62  Low: 1.63  Change(%): -66.6
Average Vol(K): 3-Month: 91938  10-Days: 51416

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
OBSV has closed above the upper band by 10.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 81.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to OBSV's normal range. The bands have been in this narrow range for 39 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 18 Sep 2020
Is it Time to Dump Obseva SA (OBSV) Stock After it Has Risen 5.43% in a Week? - InvestorsObserver

Thu, 10 Sep 2020
How Will the Market React to Obseva SA (OBSV) Stock Getting a Neutral Rating - InvestorsObserver

Tue, 08 Sep 2020
ObsEva SA to present at the H.C Wainwright 22nd Annual Global Investment Virtual Conference, September 14-16, 2020 - GlobeNewswire

Fri, 04 Sep 2020
ObsEva SA (NASDAQ:OBSV) share price rebounds 39.85% from the lows – but can it keep going? - Marketing Sentinel

Fri, 04 Sep 2020
Where Does Obseva SA (OBSV) Stock Fall in the Biotechnology Field? - InvestorsObserver

Thu, 03 Sep 2020
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement Priced At-The-Market of Common Shares and 15-Month Purchase Warrants for Potential Additional Gross Proceeds of $23.9 Million - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48
Shares Float (M) 32
% Held by Insiders 6.08
% Held by Institutions 52.07
Shares Short (K) 1,750
Shares Short P. Month (K) 1,670

Stock Financials

EPS -1.953
EPS Est This Year -2.460
EPS Est Next Year -2.480
Book Value (p.s.) 0.490
Profit Margin
Operating Margin -475216.66
Return on Assets (ttm) -51.5
Return on Equity (ttm) -149.8
Qtrly Rev. Growth 300.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.780
Qtrly Earnings Growth
Operating Cash Flow (M) -84
Levered Free Cash Flow (M) -58

Stock Valuations

PE Ratio -1.53
PEG Ratio
Price to Book value 6.08
Price to Sales 7946.67
Price to Cash Flow -1.70

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.